FDA Inspection
US Specialty Formulations LLCUS Specialty Formulations LLC – FDA Inspection, Mar 26, 2025
Record Details
This FDA Inspection record concerns US Specialty Formulations LLC, with an inspection on March 26, 2025, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · e25bcef3-888a-4f3e-b64b-223257e43fa2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265449
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of US Specialty Formulations LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 14, 2026 | Not classified | Philadelphia District Office | Drug Quality Assurance |
| July 2, 2024 | OAI | Drug Quality Assurance | |
| April 26, 2022 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| July 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for US Specialty Formulations LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.